- United States
- /
- Life Sciences
- /
- NYSE:A
Agilent Technologies (A): Examining Valuation After Recent Share Price Rally
Reviewed by Simply Wall St
See our latest analysis for Agilent Technologies.
With the share price up over 24% in the past 90 days, Agilent Technologies is certainly showing renewed momentum. Looking at the bigger picture, its 1-year total shareholder return stands at nearly 14%, reminding investors that performance has rebounded after a sluggish multi-year stretch.
If the recent uptick in life sciences has you thinking broadly, it could be the perfect moment to discover opportunities across the sector. See the full selection with our See the full list for free..
The real question is whether Agilent Technologies' recent rally leaves the stock undervalued or if the latest gains reflect an optimistic market that has already priced in the company’s future growth. Is there still real upside for investors?
Most Popular Narrative: Fairly Valued
Taking the most closely tracked narrative as a reference point, Agilent Technologies' fair value is pegged at $152.33, almost perfectly aligning with its latest closing price of $151.25. This razor-thin gap suggests the market's current pricing is closely mirroring the expectations found in the consensus outlook, inviting investors to weigh the assumptions behind this equilibrium.
Strategic investments in higher-margin recurring revenue streams, including consumables, software, services, and digital platforms, are gaining traction. CrossLab and services are delivering consistent mid-single-digit growth and high customer satisfaction, indicating further margin expansion and greater earnings stability in future periods.
Want to know why this outlook could hold firm in the years ahead? The valuation hinges on steady gains from fast-growing revenue streams and ambitious improvements in profitability, factors within industry dynamics that might surprise you. Find out which core financial bets tip the scales behind this fair value.
Result: Fair Value of $152.33 (ABOUT RIGHT)
Have a read of the narrative in full and understand what's behind the forecasts.
However, persistent funding pressures in academic research and rising global tariffs remain key risks that could affect the long-term growth outlook for Agilent Technologies.
Find out about the key risks to this Agilent Technologies narrative.
Another View: Multiples Comparison Raises Questions
Looking at valuation through the lens of earnings multiples, Agilent Technologies trades at 35.1 times earnings, just below the peer average of 35.3, but notably higher than the industry average of 34.9 and above the fair ratio estimate of 24.2. This premium suggests investors are counting on further growth or stability. Does paying up today risk being caught if market sentiment shifts?
See what the numbers say about this price — find out in our valuation breakdown.
Build Your Own Agilent Technologies Narrative
If you think another story is taking shape or want to dig into the data yourself, it’s easy to craft your own view in just a few minutes. Do it your way.
A good starting point is our analysis highlighting 1 key reward investors are optimistic about regarding Agilent Technologies.
Looking for more smart investment moves?
Don't let this momentum pass you by. There are more exciting opportunities beyond Agilent Technologies waiting for your next great idea. Here’s where you can find them:
- Capture the upside in digital assets and fintech by checking out these 81 cryptocurrency and blockchain stocks poised for innovation in payment systems and blockchain advancements.
- Uncover stocks harnessing the AI revolution. See these 25 AI penny stocks with robust algorithms and market-defining potential before the crowd catches up.
- Maximize portfolio value by targeting these 917 undervalued stocks based on cash flows overlooked by the market and offering compelling cash flow-driven upside.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:A
Agilent Technologies
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Excellent balance sheet with limited growth.
Similar Companies
Market Insights
Community Narratives

